4.5 Article

Crystal structures of the human histone H4K20 methyltransferases SUV420H1 and SUV420H2

期刊

FEBS LETTERS
卷 587, 期 23, 页码 3859-3868

出版社

WILEY
DOI: 10.1016/j.febslet.2013.10.020

关键词

Histone methyltransferase; SET domain; Crystal structure; SUV420H1; SUV420H2

资金

  1. AbbVie [1097737]
  2. Boehringer Ingelheim
  3. Canada Foundation for Innovation
  4. Canadian Institutes for Health Research
  5. Genome Canada through the Ontario Genomics Institute [OGI-055]
  6. GlaxoSmithKline
  7. Janssen
  8. Lilly Canada
  9. Novartis Research Foundation
  10. Ontario Ministry of Economic Development and Innovation
  11. Pfizer
  12. Takeda
  13. Wellcome Trust [092809/Z/10/Z]

向作者/读者索取更多资源

SUV420H1 and SUV420H2 are two highly homologous enzymes that methylate lysine 20 of histone H4 (H4K20), a mark that has been implicated in transcriptional regulation. In this study, we present the high-resolution crystal structures of human SUV420H1 and SUV420H2 in complex with SAM, and report their substrate specificity. Both methyltransferases have a unique N-terminal domain and Zn-binding post-SET domain, and prefer the monomethylated histone H4K20 as a substrate in vitro. No histone H4K20 trimethylation activity was detected by our radioactivity-based assay for either enzyme, consistent with the presence of a conserved serine residue that forms a hydrogen bond with the target lysine side-chain and limits the methylation level. (C) 2013 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据